• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechAI

Scientist says the one thing everyone hates about AI is ultimately what helped him win a Nobel Prize

Dave Smith
By
Dave Smith
Dave Smith
Editor, U.S. News
Down Arrow Button Icon
Dave Smith
By
Dave Smith
Dave Smith
Editor, U.S. News
Down Arrow Button Icon
December 24, 2024, 10:50 AM ET
Photo of David Baker
David Baker gives his Nobel Prize lecture at Stockholm University on Dec. 8, 2024.Pontus Lundahl / TT News Agency / AFP—Getty Images
  • AI has the tendency to “hallucinate,” or make up information that it thinks is real—and even seems legitimate, or plausible. But while people criticize AI for its ability to hallucinate, scientists celebrate this side effect. They say it’s helped make new inventions and discoveries possible.

In October, David Baker was one of three scientists to win the Nobel Prize in chemistry. Baker, from the University of Washington, won for using computer software to invent a new protein.

Recommended Video

In an interview with the New York Times before the prize announcement, Baker said AI hallucinations were central to “making proteins from scratch,” adding they helped his lab to design around 10 million “all brand-new” proteins that “don’t occur in nature.”

“Things are moving fast,” he said. “Even scientists who do proteins for a living don’t know how far things have come.”

AI hallucinations happen when artificial intelligence makes up information that it believes is true. And for many folks, at first glance, that information will likely appear to be factual, as AI can roll out fake information that looks highly plausible. But while this has become a topic of criticism for many people, Baker’s example highlights its potential usefulness.

“The public thinks it’s all bad,” Amy McGovern, principal investigator for the federal AI institute AI2ES, told the NYT. “But it’s actually giving scientists new ideas.”

James Collins, a biological engineering professor at MIT, also recently praised hallucinations for accelerating his research into new types of antibiotics. “We’re exploring,” he said. “We’re asking the models to come up with completely new molecules.”

On the topic of molecules, the Nobel Prize committee didn’t seem fazed by Baker’s use of AI, or its hallucinations, in his research. Instead, it said his team was able to produce “one imaginative protein creation after another.”

Baker hopes AI can help him create more proteins “that actually do things,” like break up the abnormal protein structures many believe to be associated with neurodegenerative diseases like Alzheimer’s.

Fortune Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Fortune Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Author
Dave Smith
By Dave SmithEditor, U.S. News

Dave Smith is a writer and editor who previously has been published in Business Insider, Newsweek, ABC News, and USA TODAY.

See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.